glyburide and dapagliflozin

glyburide has been researched along with dapagliflozin in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's3 (100.00)2.80

Authors

AuthorsStudies
Barreto, J; Bonilha, I; Breder, I; Breder, JC; Carvalho, LSF; Cavalcante, P; Cintra, RMR; de Lima-Junior, JC; do Carmo, HRP; Kimura-Medorima, ST; Moreira, C; Moura, FA; Munhoz, DB; Nadruz, W; Oliveira, DC; Quinaglia, T; Soares, AAS; Sposito, AC1
Barreto, J; Breder, I; Cintra, RM; de Carvalho, LSF; Guerra-JĂșnior, G; Kimura-Medorima, ST; Munhoz, DB; Muscelli, E; Nadruz, W; Quinaglia, T; Soares, AAS; Sposito, AC; Wolf, VLW1
Arieta, CEL; Barreto, J; Breder, I; Breder, JC; Carvalho, LSF; Chaves, FRP; Cintra, RMR; Fernandes, VHR; Kimura-Medorima, ST; Munhoz, DB; Nadruz, W; Quinaglia, T; Soares, AAS; Sposito, AC1

Trials

3 trial(s) available for glyburide and dapagliflozin

ArticleYear
Dapagliflozin effect on endothelial dysfunction in diabetic patients with atherosclerotic disease: a randomized active-controlled trial.
    Cardiovascular diabetology, 2021, 03-26, Volume: 20, Issue:1

    Topics: Adult; Aged; Benzhydryl Compounds; Biomarkers; Blood Glucose; Brazil; Carotid Artery Diseases; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Endothelium, Vascular; Female; Glucosides; Glyburide; Glycated Hemoglobin; Humans; Male; Metformin; Middle Aged; Prospective Studies; Sodium-Glucose Transporter 2 Inhibitors; Time Factors; Treatment Outcome; Vasodilation

2021
Dapagliflozin increases the lean-to total mass ratio in type 2 diabetes mellitus.
    Nutrition & diabetes, 2021, 06-12, Volume: 11, Issue:1

    Topics: Absorptiometry, Photon; Adult; Aged; Benzhydryl Compounds; Blood Glucose; Body Composition; Body Weight; Carotid Artery Diseases; Diabetes Mellitus, Type 2; Female; Glucosides; Glyburide; Glycated Hemoglobin; Hand Strength; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Treatment Outcome

2021
Dapagliflozin increases retinal thickness in type 2 diabetic patients as compared with glibenclamide: A randomized controlled trial.
    Diabetes & metabolism, 2021, Volume: 47, Issue:6

    Topics: Benzhydryl Compounds; Blood Glucose; Diabetes Mellitus, Type 2; Glucosides; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Middle Aged; Retina; Treatment Outcome

2021